Real-time enrollment status for this primary renal cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 10:35 AM UTC
| NCT Number | NCT07767500 |
| Recruiting Status | Recruiting |
| Condition | Primary Renal Cancer |
| Phase | NA |
| Target Enrollment | 30 participants |
| Active Locations | 1 sites in the US |
| Sponsor | NYU Langone Health |
| Last Updated on CT.gov | August 21, 2026 (Aug 21, 2026) |
As of October 16, 2026: Clinical trial NCT07767500 is currently recruiting participants. This na study for primary renal cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by NYU Langone Health. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07767500 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07767500 was last updated Aug 21, 2026 (August 21, 2026). HelloStudys verifies this status automatically.